Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
On Oct. 23, 2025, GSK announced the US Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf)…
-
-
Ancient DNA Database Faces Uncertain Future after Funding Expires
On Oct. 23, 2025, researchers at a Harvard Medical School laboratory announced they are uncertain how they will…
-
CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology
On Oct. 23, 2025, CareDx announced the publication of the second study from Surveillance HeartCare Outcomes Registry (SHORE)…
-
Alkermes Announces Agreement to Acquire Avadel Pharmaceuticals for $2.1 billion
On Oct. 22, 2025, Alkermes and Avadel Pharmaceuticals announced the companies have entered into a definitive agreement under…
-
South Carolina Department of Public Health Confirms Measles Outbreak
On Oct. 22, 2025, the South Carolina Department of Public Health (SCDPH) announced it is actively responding to…
-
Pigs developed to be resistant to deadly virus
On Oct. 22, 2025, a Roslin Institute led team announced they have developed pigs that are resistant to…
-
Blackstone, and TPG announce plans to take medtech Hologic private for $18.3 billion
On Oct. 21, 2025, private equity firms Blackstone and TPG said they will buy medical diagnostics firm Hologic…
-
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | USDA | Vaccine | Veterinary
Fall Migration brings increased risk of Highly Pathogenic Avian Influenza
On Oct. 21, 2025, the Oregon Department of Agriculture has warned that as wild birds begin to migrate…
-
Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia
On Oct. 20, 2025, Merck announced the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility…
-
Glaukos Announces FDA Approval of Epioxa™
On Oct. 20, 2025, Glaukos announced today the U.S. Food and Drug Administration (FDA) approved its Epioxa™ HD…
-
The Jackson Laboratory acquires New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patients
On Oct. 20, 2025, The Jackson Laboratory (JAX), a global leader in genetics and genomic medicine, announced it…
-
ACG to invest $200 million in U.S. hard-shell capsule manufacturing
On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…
-
GRAIL PATHFINDER 2 Results Show Galleri ® Multi-Cancer Early Detection Blood Test Increased Cancer Detection
On Oct. 18, 2025, GRAIL announced that positive performance and safety results from its registrational PATHFINDER 2 study…
-
Setback for Roche in Natco Pharma case as India Supreme Court allows generic drug sales
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
-
China’s Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…
-
FDA approves Novo Nordisk’s oral semaglutide for cardiovascular risk reduction in adults with type 2 diabetes
On Oct. 17, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved Rybelsus®, the only oral GLP-1…
-
Study finds no link between mRNA COVID vaccines early in pregnancy and birth defects
On Oct. 15, 2025, mRNA COVID-19 vaccination in the first trimester of pregnancy isn’t tied to an elevated…
-
Broad Clinical Labs sets new GUINNESS WORLD RECORDS™ title for fastest DNA sequencing technique
On Oct. 15, 2025, Broad Clinical Labs, in collaboration with Roche Sequencing Solutions and Boston Children’s Hospital, announced…
-
Novo Nordisk signs up to $2.1 billion licensing deal with Omeros in rare disease push
On Oct. 15, 2025, Danish drugmaker Novo Nordisk and Omeros announced they have signed a licensing deal worth…
-
Japan declares a flu epidemic — what this means for other nations
On Oct. 14, 2025, Japan’s health authorities have declared an influenza epidemic, with thousands of people infected with…
-
New Human Liver Organoid Platform Predicts Immune-Mediated Drug Toxicity
On Oct. 14, 2025, researchers at Cincinnati Children’s in collaboration with Roche, have developed a next-generation human liver…
-
Multidisciplinary study finds estrogen could aid in therapies for progressive multiple sclerosis
On Oct. 13, 2025, researchers from Texas A&M University announced they have identified two estrogens, estradiol and estriol,…
-
WHO warns of widespread resistance to common antibiotics worldwide
On Oct. 13, 2025, the World Health Organization (WHO) reported that one in six laboratory-confirmed bacterial infections causing…
-
Biotechnology | Diagnostics | Disease | FDA | Neurology | NIH
Alzheimer’s Association Welcomes FDA Clearance of First Blood Test for Use in Primary Care to Rule Out Alzheimer’s-Related Amyloid Pathology
On Oct. 13, 2025, the U.S. Food and Drug Administration (FDA) announces it has cleared the Elecsys pTau181…
-
New lab-grown human embryo model produces blood cells
On Oct. 13, 2025, University of Cambridge scientists announced they have used human stem cells to create three-dimensional…
-
Bristol Myers Squibb Acquires Cell Therapy Portfolio with Acquisition of Orbital Therapeutics for $1.5 billion in cash
On Oct. 10, 2025, Bristol Myers Squibb (BMS) and Orbital Therapeutics announced a definitive agreement under which BMS…
-
U.S. FDA approves Boehringer’s JASCAYD® (nerandomilast) tablets as first new treatment option for adults with IPF in over a decade
On Oct. 9, 2025, Boehringer Ingelheim’s JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug…
-
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept)
On Oct. 9, 2025, Celltrion announced announced that the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), biosimilar…
-
Pig liver transplant into a living person edges it closer to the norm
On Oct. 9, 2025, Beicheng Sun at Anhui Medical University in China and his colleagues have reported the…
-
Biotechnology | Disease | Genomics | Oncology
Revolutionary blood test for ME / Chronic Fatigue unveiled
On Oct. 8, 2025, scientists at the University of East Anglia and Oxford Biodynamics announced they have developed a…
